MTT assay

The MTT assay measures formation of colored formazan when metabolically active biological cells reduce the tetrazolium salt MTT. The initially yellow reagent produces purple crystals; those crystals are solubilized before optical measurement with a multiwell spectrophotometer or microplate reader. The Roche instructions describe this chemical conversion and readout explicitly.^[ref]

The measured endpoint is a metabolic color response. Under a calibrated linear model it can track viable-cell number, but per-cell activity also matters. Tim R. Mosmann's original 1983 paper noted that the signal depends on cellular activation as well as the presence of living cells.^[ref]

For an original normalized comparison, suppose treated wells give absorbance $A_t=0.62$, matched untreated controls $A_c=1.02$ and the reagent blank $A_b=0.02$. The blank-corrected signal ratio isThis means $60\%$ of the control's measured MTT signal. It does not establish that $40\%$ of cells died. In $A-A_b=qN$, fewer viable cells $N$ and lower response per cell $q$ can produce the same result.

A calibration series with independently known cell numbers tests the useful response range. Cell-free wells containing the tested material help identify direct color, light scattering or reagent interactions; a vehicle control separates treatment-solvent effects. Complete and comparable solubilization matters because the readout concerns the colored solution rather than an arbitrary suspension of crystals.

For a cytotoxicity study, complementing this assay with a cell count or membrane-integrity endpoint can distinguish some ambiguities. Incubation history, cell state and observation time belong in the interpretation. MTT color formation, cell proliferation and cell death are related experimental questions, not interchangeable definitions.